STIPE Therapeutics ApS
CVRCVR number39691175Under konkurs
Core data
Name | STIPE Therapeutics ApS |
Address | Axeltorv 2, 1609, København V |
Founded | Jul 2, 2018 |
Employees (CVR) | 1 |
Locations (P-units) | 3View locations |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | STIPE Therapeutics ApS |
Address | Axeltorv 2, 1609, København V |
Founded | Jul 2, 2018 |
Employees (CVR) | 1 |
Locations (P-units) | 3View locations |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of STIPE Therapeutics ApS
Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.
Free account
Description
The company's key activity is to develop novel treatments that focuses on harnessing the innate immune system to battle cancer.
Financials
| Reporting period | |||||||
|---|---|---|---|---|---|---|---|
| Gross profit | -842,285 | ||||||
| Operating profit | -1,499,764 | ||||||
| Profit before tax | 1,448,748 | ||||||
| Net income | 1,448,748 | ||||||
| Total assets | 1,123,658 | ||||||
| Equity | 1,087,512 | ||||||
| Avg. employees | 5 | ||||||
2019–2024 Unlock financial history | |||||||
Datapublica Risk Score
Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
0 · Low100 · High
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
People
No current people or role data available
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| EY Godkendt Revisionspartnerselskab | AuditorPeter U. Faurschou | RoleState Authorised Public Accountant | FromJul 3, 2025 |
| — | AuditorChristian Jøker | RoleState Authorised Public Accountant | FromJul 3, 2025 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership25–33.32 % | Voting rights25 % | FromSep 12, 2023 | |
| Ownership20–24.99 % | Voting rights20 % | FromSep 8, 2023 | |
Unknown Other Participant | Ownership20–24.99 % | Voting rights20 % | FromSep 5, 2023 |
| Ownership10–14.99 % | Voting rights10 % | FromDec 2, 2021 | |
| Ownership5–9.99 % | Voting rights5 % | FromDec 2, 2021 |
Child companies
| Company | Ownership | Voting rights | From | To |
|---|---|---|---|---|
| Ownership100 % | Voting rights100 % | FromNov 21, 2023 | ToNov 22, 2023 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| NOVO NORDISK FONDEN | 27–37.07 % | |
| 🇩🇪Wellington Partners V Life Sciences Fund | Ownership through Direct | 20–24.99 % |
| Martin Roelsgaard Jakobsen | Ownership through | 6.66–13.49 % |
| 🇱🇺European Investment Fund | Ownership through | 6.66–12.5 % |
| Danmarks Eksport- og Investeringsfond | 5.5–9.58 % | |
| Claus Elsborg Olesen | Ownership through | 5–9.99 % |
| Andreas Roelsgaard Madsen | Ownership through | 1–2.25 % |
| Frederik Roelsgaard Madsen | Ownership through | 1–2.25 % |
| Signe Roelsgaard Madsen | Ownership through | 1–2.25 % |
| Arbejdsmarkedets Tillægspension | 0.15–0.5 % | |
| A.P. MØLLER OG HUSTRU CHASTINE MC-KINNEY MØLLERS FOND TIL ALMENE FORMAAL | 0.06–0.19 % | |
| Fagligt Fælles Forbund | 0.04–0.25 % | |
| 🇺🇸BlackRock, Inc | 0.01–0.08 % | |
| DANSK EL-FORBUND | 0.01–0.08 % | |
| MALERFORBUNDET I DANMARK | 0.01–0.08 % | |
| BLIK OG RØR ARBEJDERFORBUNDET I DANMARK | 0–0.05 % | |
| DI | 0–0.05 % |